1. Home
  2. RCUS vs TPB Comparison

RCUS vs TPB Comparison

Compare RCUS & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$20.11

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Turning Point Brands Inc.

TPB

Turning Point Brands Inc.

HOLD

Current Price

$125.00

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
TPB
Founded
2015
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Tobacco
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
RCUS
TPB
Price
$20.11
$125.00
Analyst Decision
Buy
Buy
Analyst Count
9
3
Target Price
$28.89
$115.00
AVG Volume (30 Days)
1.2M
315.7K
Earning Date
02-24-2026
03-05-2026
Dividend Yield
N/A
0.24%
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$240,000,000.00
$435,716,000.00
Revenue This Year
N/A
$29.51
Revenue Next Year
N/A
$11.08
P/E Ratio
N/A
$633.24
Revenue Growth
N/A
51.72
52 Week Low
$6.50
$51.48
52 Week High
$26.40
$129.94

Technical Indicators

Market Signals
Indicator
RCUS
TPB
Relative Strength Index (RSI) 38.96 64.99
Support Level $20.79 $123.98
Resistance Level $22.29 $124.73
Average True Range (ATR) 1.13 3.96
MACD -0.20 0.33
Stochastic Oscillator 0.45 62.73

Price Performance

Historical Comparison
RCUS
TPB

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: